Background Stomach adenocarcinoma (STAD) is one of the most prevalent malignances,
ranking fifth in incidence and third in mortality among all malignances. Interferon regulatory …

Background: Insulin-like growth factor binding protein-7 (IGFBP7) contributes to multiple
biological processes in various tumors. However, the role of IGFBP7 in gastric cancer (GC) …

Interferon regulatory factor 6 (IRF6) acts as a tumor suppressor and controls cell
differentiation in ectodermal and craniofacial tissues by regulating expression of target …

Background Interferon-induced transmembrane proteins (IFITMs) are a family of proteins
which functions mainly include controlling cell proliferation, promoting homotypic cell …

Precision medicine for gastric cancer (GC) is still an unsolved issue, because most available
target drugs are not specifically designed for GC. Exploring novel signaling molecules with …

Background Stomach adenocarcinoma (STAD) presents a challenge given its advanced
stage at diagnosis and poor prognosis. Integrin subunit alpha 11 (ITGA11) encodes alpha …

The aim of this study is to investigate the expression levels and clinical significance of ILF2
in gastric cancer. The mRNA and protein expression levels of ILF2 were, respectively …

The role of the IFI6 gene has been described in several cancers, but its involvement in
esophageal cancer (ESCA) remains unclear. This study aimed to identify novel prognostic …

Interleukin enhancer‑binding factor 3 (ILF3) may function as a transcriptional coactivator and
has been reported to be involved in tumor proliferation and metastasis; however, its role and …

Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …